The 5α-reductase type II A49T and V89L allelic variants are more common in men with prostate cancer compared with the general population

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2005年 / 4卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 21 条
  • [1] The 5α-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population
    Giwercman, YL
    Abrahamsson, PA
    Giwercman, A
    Gadaleanu, V
    Ahlgren, G
    EUROPEAN UROLOGY, 2005, 48 (04) : 679 - 685
  • [2] A49T, V89L and TA repeat polymorphisms of steroid 5α-reductase type II and breast cancer risk in Japanese women
    Chunxia Yang
    Nobuyuki Hamajima
    Hiroji Iwata
    Toshiko Saito
    Keitaro Matsuo
    Kaoru Hirose
    Manami Inoue
    Toshiro Takezaki
    Kazuo Tajima
    Breast Cancer Research, 4
  • [3] The association of steroid 5-alpha reductase type-II gene polymorphisms (A49T and V89L) with prostate cancer risk in African population: A systematic review and meta-analysis
    Ayeni, Timothy Oluwatimileyin
    Bajepade, Tobiloba Isaac
    Akanni, Mosunmola Hannah
    Pirisola, Ayomikun Joshua
    Oluwajembola, Abimbola Mary
    Chinedu, Shalom Nwodo
    SCIENTIFIC AFRICAN, 2024, 26
  • [4] Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis
    Qiaoxin Li
    Yao Zhu
    Jing He
    Mengyun Wang
    Meiling Zhu
    Tingyan Shi
    Lixin Qiu
    Dingwei Ye
    Qingyi Wei
    Molecular Biology Reports, 2013, 40 : 3597 - 3608
  • [5] Association of missense substitution of A49T and V89L in the SRD5A2 gene with prostate cancer in Turkish patients
    Neijmann, Sebnem Tekin
    Kural, Alev
    Tinay, Ilker
    Livaoglu, Ayten
    Cevlik, Tulay
    Turkeri, Levent
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2017, 42 (01): : 37 - 43
  • [6] Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis
    Li, Qiaoxin
    Zhu, Yao
    He, Jing
    Wang, Mengyun
    Zhu, Meiling
    Shi, Tingyan
    Qiu, Lixin
    Ye, Dingwei
    Wei, Qingyi
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (05) : 3597 - 3608
  • [7] Steroid 5-α reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study
    Pearce, CL
    Makridakis, NM
    Ross, RK
    Pike, MC
    Kolonel, LN
    Henderson, BE
    Reichardt, JKV
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (04) : 417 - 418
  • [8] The V89L polymorphism in the 5α-reductase type 2 gene and risk of prostate cancer
    Febbo, PG
    Kantoff, PW
    Platz, EA
    Casey, D
    Batter, S
    Giovannucci, E
    Hennekens, CH
    Stampfer, MJ
    CANCER RESEARCH, 1999, 59 (23) : 5878 - 5881
  • [9] A49T, V89L and TA repeat polymorphisms of steroid 5α-reductase type II and breast cancer risk in Japanese women -: art. no. R8
    Yang, CX
    Hamajima, N
    Iwata, H
    Saito, T
    Matsuo, K
    Hirose, K
    Inoue, M
    Takezaki, T
    Tajima, K
    BREAST CANCER RESEARCH, 2002, 4 (04):
  • [10] Association between steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and prostate cancer risk: a meta-analysis study
    Zhang, Gang
    Yin, Tao
    Zhang, Bin
    Liang, Ming
    Ding, Jiandong
    Cao, Longqiao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (04): : 7312 - 7324
123